Smithfield Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.88M | Sell |
66,977
-1,700
| -2% | -$45.3K | 0.08% | 117 |
|
|
2025
Q4 | $1.71M | Buy |
68,677
+2,979
| +5% | +$75.1K | 0.08% | 114 |
|
|
2025
Q3 | $1.67M | Buy |
65,698
+3,340
| +5% | +$82.4K | 0.07% | 117 |
|
|
2025
Q2 | $1.51M | Sell |
62,358
-8,132
| -12% | -$190K | 0.07% | 126 |
|
|
2025
Q1 | $1.79M | Sell |
70,490
-2,490
| -3% | -$65.2K | 0.09% | 105 |
|
|
2024
Q4 | $1.93M | Sell |
72,980
-620
| -0.8% | -$16.8K | 0.1% | 105 |
|
|
2024
Q3 | $2.12M | Buy |
73,600
+1,078
| +1% | +$31.4K | 0.1% | 100 |
|
|
2024
Q2 | $2.02M | Sell |
72,522
-2,220
| -3% | -$61.1K | 0.11% | 97 |
|
|
2024
Q1 | $2.07M | Sell |
74,742
-14,605
| -16% | -$405K | 0.11% | 99 |
|
|
2023
Q4 | $2.56M | Sell |
89,347
-22,085
| -20% | -$668K | 0.14% | 84 |
|
|
2023
Q3 | $3.69M | Sell |
111,432
-714
| -0.6% | -$25.2K | 0.23% | 62 |
|
|
2023
Q2 | $4.12M | Sell |
112,146
-11,326
| -9% | -$441K | 0.25% | 55 |
|
|
2023
Q1 | $5.03M | Buy |
123,472
+8,351
| +7% | +$361K | 0.32% | 46 |
|
|
2022
Q4 | $5.92M | Sell |
115,121
-772
| -0.7% | -$37K | 0.4% | 42 |
|
|
2022
Q3 | $5.07M | Buy |
115,893
+1,322
| +1% | +$64.2K | 0.37% | 44 |
|
|
2022
Q2 | $6.02M | Buy |
114,571
+8,971
| +8% | +$457K | 0.42% | 36 |
|
|
2022
Q1 | $5.48M | Buy |
105,600
+605
| +0.6% | +$31.4K | 0.35% | 47 |
|
|
2021
Q4 | $6.2M | Sell |
104,995
-216
| -0.2% | -$10.7K | 0.38% | 42 |
|
|
2021
Q3 | $4.52M | Buy |
105,211
+1,250
| +1% | +$55.4K | 0.3% | 48 |
|
|
2021
Q2 | $4.07M | Sell |
103,961
-2,282
| -2% | -$88.7K | 0.27% | 56 |
|
|
2021
Q1 | $3.85M | Sell |
106,243
-796
| -0.7% | -$28.3K | 0.27% | 58 |
|
|
2020
Q4 | $3.94M | Sell |
107,039
-7,512
| -7% | -$276K | 0.29% | 55 |
|
|
2020
Q3 | $3.99M | Buy |
114,551
+1,654
| +1% | +$58K | 0.33% | 46 |
|
|
2020
Q2 | $3.5M | Sell |
112,897
-3,702
| -3% | -$126K | 0.32% | 47 |
|
|
2020
Q1 | $3.61M | Sell |
116,599
-2,176
| -2% | -$74.1K | 0.38% | 41 |
|
|
2019
Q4 | $4.42M | Sell |
118,775
-2,077
| -2% | -$74K | 0.41% | 43 |
|
|
2019
Q3 | $4.12M | Buy |
120,852
+2,386
| +2% | +$86.8K | 0.41% | 41 |
|
|
2019
Q2 | $4.87M | Buy |
118,466
+791
| +0.7% | +$31.4K | 0.5% | 35 |
|
|
2019
Q1 | $4.74M | Sell |
117,675
-65
| -0.1% | -$2.6K | 0.51% | 33 |
|
|
2018
Q4 | $4.88M | Buy |
117,740
+9,858
| +9% | +$409K | 0.57% | 30 |
|
|
2018
Q3 | $4.51M | Buy |
107,882
+732
| +0.7% | +$28.2K | 0.49% | 35 |
|
|
2018
Q2 | $3.69M | Buy |
107,150
+3,630
| +4% | +$124K | 0.43% | 37 |
|
|
2018
Q1 | $3.48M | Buy |
103,520
+1,034
| +1% | +$35.5K | 0.42% | 42 |
|
|
2017
Q4 | $3.52M | Buy |
102,486
+7,207
| +8% | +$246K | 0.43% | 42 |
|
|
2017
Q3 | $3.23M | Buy |
95,279
+2,389
| +3% | +$76.8K | 0.44% | 39 |
|
|
2017
Q2 | $2.96M | Buy |
92,890
+844
| +0.9% | +$26.6K | 0.43% | 40 |
|
|
2017
Q1 | $2.99M | Sell |
92,046
-1,381
| -1% | -$43.5K | 0.47% | 38 |
|
|
2016
Q4 | $2.88M | Buy |
93,427
+3,499
| +4% | +$107K | 0.48% | 34 |
|
|
2016
Q3 | $2.89M | Buy |
89,928
+6,985
| +8% | +$234K | 0.52% | 30 |
|
|
2016
Q2 | $2.77M | Buy |
82,943
+3,143
| +4% | +$100K | 0.52% | 30 |
|
|
2016
Q1 | $2.24M | Buy |
79,800
+468
| +0.6% | +$13.4K | 0.44% | 38 |
|
|
2015
Q4 | $2.43M | Buy |
79,332
+1,859
| +2% | +$58.5K | 0.5% | 32 |
|
|
2015
Q3 | $2.31M | Buy |
77,473
+4,533
| +6% | +$145K | 0.49% | 31 |
|
|
2015
Q2 | $2.32M | Sell |
72,940
-6,583
| -8% | -$215K | 0.46% | 34 |
|
|
2015
Q1 | $2.63M | Sell |
79,523
-3,041
| -4% | -$96.7K | 0.52% | 32 |
|
|
2014
Q4 | $2.44M | Sell |
82,564
-9,050
| -10% | -$259K | 0.5% | 31 |
|
|
2014
Q3 | $2.57M | Sell |
91,614
-95
| -0.1% | -$2.67K | 0.52% | 32 |
|
|
2014
Q2 | $2.58M | Sell |
91,709
-6,431
| -7% | -$183K | 0.51% | 34 |
|
|
2014
Q1 | $2.99M | Sell |
98,140
-3,949
| -4% | -$118K | 0.6% | 32 |
|
|
2013
Q4 | $2.97M | Buy |
102,089
+3,442
| +3% | +$100K | 0.6% | 30 |
|
|
2013
Q3 | $2.69M | Buy |
98,647
+1,781
| +2% | +$48.5K | 0.62% | 28 |
|
|
2013
Q2 | $2.57M | Buy |
+96,866
| New | +$2.68M | 0.62% | 29 |
|
Other funds holding PFE
VCM
VPM
Smithfield Trust's PFE Position: Q1 2026 in Review
Smithfield Trust reduced its Pfizer (PFE) stake by 2.5% in Q1 2026, selling an estimated $45.3K and leaving 66,977 shares worth $1.88M. The position accounts for 0.08% of the portfolio, ranked #117.
Smithfield Trust first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.2M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Smithfield Trust held 66,977 shares of Pfizer worth $1.88M as of Q1 2026.
- Smithfield Trust sold 1,700 Pfizer shares in Q1 2026, an estimated $45.3K.
- Pfizer made up 0.08% of Smithfield Trust's portfolio in Q1 2026, its #117 holding.
- Smithfield Trust first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Smithfield Trust's Pfizer position peaked at $6.2M in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.